Market Indices
Latest News
 |
BMO Capital analyst issues MARKET PERFORM recommendation for INFY on...
January 15, 2026 INFY 10.96% |
| ||
| ||
| ||
|
Price Targets
from Wells Fargo issued a price target of $1,450.00 for ASML on 2026-01-15 11:33:26.The adjusted price target was set to $1,450.00.At the time of the announcement, ASML...
January 15, 2026 ASML -0.51%
from Morgan Stanley issued a price target of $148.00 for PDD on 2026-01-15 11:16:36.The adjusted price target was set to $148.00.At the time of the announcement, PDD...
January 15, 2026 PDD -3.98%
Leon Chen from KGI Securities issued a price target of $1,415.00 for ASML on 2026-01-15 09:59:54.The adjusted price target was set to $1,415.00.At the time of the announcement,
January 15, 2026 ASML -0.51%
from RBC Capital issued a price target of $1,550.00 for ASML on 2026-01-14 21:25:04.The adjusted price target was set to $1,550.00.At the time of the announcement, ASML...
January 14, 2026 ASML -0.51%
Sumeet Jain from Goldman Sachs issued a price target of $19.10 for INFY on 2026-01-14 20:21:00.The adjusted price target was set to $19.10.At the time of the announcement,
January 14, 2026 INFY 10.96%
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 5.00%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA 0.38%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK -2.70%